A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study
Artikel i vetenskaplig tidskrift, 2019

Limited information exists on the impact of flavonoid intake on nonalcoholic fatty liver disease (NAFLD). We evaluated the link between flavonoid intake, liver tests and risk of NAFLD in a randomly selected sample of US adults (from the National Health and Nutrition Examination Survey, NHANES, 2005–2010). Of the 17,685 participants, 46.9% were men and 45.4% had NAFLD. NAFLD patients had a significantly lower mean flavonoid intake than healthy individuals (111.3±3.6 vs. 201.3±2.3 mg/d, respectively; P<.001). Fatty liver index (FLI) and serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were significantly higher in the first tertile (T1) of flavonoid intake compared with the highest tertile (T3: with the highest flavonoid intake) (FLI: 67.1 vs. 36.2, AST: 31.2 VS 26.8 U/L and, ALT: 34.2 vs. 24.2 U/L, respectively; P<.001 for all comparisons). Adjusted linear regression displayed significant and negative associations between FLI, AST, ALT and flavonoid intake (P<.001 for all comparisons). Multivariable logistic regression showed that the risk for NAFLD significantly decreased as flavonoid intake tertiles increased in a stepwise manner (odds ratio: 0.81, 95% confidence interval: 0.78–0.86). Moderation analysis revealed that C-reactive protein (CRP) strongly modulated the impact of flavonoid intake on FLI; participants with higher CRP levels benefited less from flavonoid intake compared with those with lower CRP concentrations. In conclusions, our results suggest a reverse significant association between flavonoid consumption, liver tests and the risk for NAFLD. Furthermore, CRP was shown to essentially moderate this relationship. These findings support recommendations for consumption of flavonoid-rich foods to prevent cardiometabolic diseases.

Fatty liver index

Aspartate aminotransferase

Flavonoid intake

Alanine aminotransferase

Nonalcoholic fatty liver disease

C-reactive protein

Författare

Mohsen Mazidi

Chalmers, Biologi och bioteknik, Livsmedelsvetenskap

Niki Katsiki

Aristotelio Panepistimio Thessalonikis

Maciej Banach

Instytut Centrum Zdrowia Matki Polki

Uniwersytet Zielonogorski

Medical University of Lodz

Journal of Nutritional Biochemistry

0955-2863 (ISSN)

Vol. 65 66-71

Ämneskategorier

Klinisk medicin

Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi

Näringslära

DOI

10.1016/j.jnutbio.2018.10.001

Mer information

Senast uppdaterat

2019-05-23